NRGHN015
OPEN TO ACCRUAL
PII Chemo (carbo+pac) or CIT (carbo+pac+cemi) PD-L1 in Squamous Carcinoma HN with Salvage(Neopolis)
UW25009
OPEN TO ACCRUAL
Identifying biomarkers of oral cancer response to neoadjuvant immunotherapy prior to surgery
UW25107
OPEN TO ACCRUAL
FORTIFI-HN01: Ph 2/3 Study of Ficerafusp Alfa (BCA101) or Placebo in Combo w/Pembro for PD-L1+ HNSCC